TY - JOUR
T1 - Review of familial cerebral cavernous malformations and report of seven additional families
AU - de Vos, Ivo J. H. M.
AU - Vreeburg, Maaike
AU - Koek, Ger H.
AU - van Steensel, Maurice A. M.
N1 - IdVis supported by the ASTAR Research Attachment Programme. MvS is supported by the Skin Research Institute of Singapore, theWellcome Trust, and the Dystrophic Epidermolysis BullosaResearch Association (DEBRA), UK
PY - 2016/10/28
Y1 - 2016/10/28
N2 - Cerebral cavernous malformations are vascular anomalies of the central nervous system characterized by clusters of enlarged, leaky capillaries. They are caused by loss-of-function mutations in KRIT1, CCM2, or PDCD10. The proteins encoded by these genes are involved in four partially interconnected signaling pathways that control angiogenesis and endothelial permeability. Cerebral cavernous malformations can occur sporadically, or as a familial autosomal dominant disorder (FCCM) with incomplete clinical and neuroradiological penetrance and great inter-individual variability. Although the clinical course is unpredictable, symptoms typically present during adult life and include headaches, focal neurological deficits, seizures, and potentially fatal stroke. In addition to neural lesions, extraneural cavernous malformations have been described in familial disease in several tissues, in particular the skin. We here present seven novel FCCM families with neurologic and cutaneous lesions. We review histopathological and clinical features and provide an update on the pathophysiology of cerebral cavernous malformations and associated cutaneous vascular lesions. © 2016 Wiley Periodicals, Inc.
AB - Cerebral cavernous malformations are vascular anomalies of the central nervous system characterized by clusters of enlarged, leaky capillaries. They are caused by loss-of-function mutations in KRIT1, CCM2, or PDCD10. The proteins encoded by these genes are involved in four partially interconnected signaling pathways that control angiogenesis and endothelial permeability. Cerebral cavernous malformations can occur sporadically, or as a familial autosomal dominant disorder (FCCM) with incomplete clinical and neuroradiological penetrance and great inter-individual variability. Although the clinical course is unpredictable, symptoms typically present during adult life and include headaches, focal neurological deficits, seizures, and potentially fatal stroke. In addition to neural lesions, extraneural cavernous malformations have been described in familial disease in several tissues, in particular the skin. We here present seven novel FCCM families with neurologic and cutaneous lesions. We review histopathological and clinical features and provide an update on the pathophysiology of cerebral cavernous malformations and associated cutaneous vascular lesions. © 2016 Wiley Periodicals, Inc.
KW - cerebral cavernous malformation
KW - CCM
KW - cutaneous cavernous malformation
U2 - 10.1002/ajmg.a.38028
DO - 10.1002/ajmg.a.38028
M3 - Review article
C2 - 27792856
SN - 1552-4825
VL - 173
SP - 338
EP - 351
JO - American Journal of Medical Genetics Part A
JF - American Journal of Medical Genetics Part A
IS - 2
ER -